Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 222 results for "vtvt"

Buy vTv Therapeutics For Its Novel Alzheimer's And Anti-Diabetic Drug Candidates.
Seeking Alpha

vTv Therapeutics Announces Presentation of Phase 2b Azeliragon...

TORONTO--(BUSINESS WIRE)-- vTv Therapeutics Inc. ( VTVT ), a clinical-stage biopharmaceutical company engaged in the discovery and development of new orally administered treatments for Alzheimer's disease and diabetes, today announced that Phase ... Yahoo! Finance UK and Ireland, 2 days ago

22 images for vtvt, 1 hour ago
Mideast Time, 1 day ago
American Banking News - Forex, 3 days ago
NDTV, 4 days ago
Rush Lane, 6 days ago
American Banking News, 3 weeks ago
SleekMoney, 3 weeks ago
American Banking News - Forex, 4 weeks ago
WKRB News, 1 month ago
SleekMoney, 4 weeks ago

Brokerages Expect vTv Therapeutics Inc. (NASDAQ:VTVT) to Post ($0.58) EPS

Shares of vTv Therapeutics Inc. (NASDAQ:VTVT) have received a consensus broker rating score of 1.00 (Strong Buy) from the four analysts that provide coverage for the company, Zacks Investment Research reports. Four investment analysts have rated the ...
 WKRB News2 days ago Zacks: vTv Therapeutics Inc. (NASDAQ:VTVT) Receives Consensus Recommendation of Strong Buy from Analysts  SleekMoney37 minutes ago vTv Therapeutics Inc. (NASDAQ:VTVT) Given $19.25 Consensus Target Price by Analysts  SleekMoney3 weeks ago Zacks: vTv Therapeutics Inc (NASDAQ:VTVT) Given Consensus Rating of Strong Buy by Brokerages  American Banking News1 month ago

vTv Therapeutics Inc. (VTVT) Rating Increased to Hold at Zacks Investment Research

vTv Therapeutics Inc. (NASDAQ:VTVT) was upgraded by Zacks Investment Research from a sell rating to a hold rating in a report released on Tuesday. According to Zacks, vTv Therapeutics Inc. is a biopharmaceutical company which is engaged in the ...
 WKRB News3 days ago 54,604 Shares in vTv Therapeutics Inc. (VTVT) Acquired by Kennedy Capital Management Inc.  Mideast Time1 day ago vTv Therapeutics Inc. (VTVT) Upgraded to Hold by Zacks Investment Research  Mideast Time2 days ago vTv Therapeutics Inc. (VTVT) Cut to Sell at Zacks Investment Research  Mideast Time2 weeks ago

Zacks: Analysts Set $19.25 Price Target for vTv Therapeutics Inc. (NASDAQ:VTVT)

vTv Therapeutics Inc. (NASDAQ:VTVT) has been given an average broker rating score of 1.00 (Strong Buy) from the four brokers that provide coverage for the stock, Zacks Investment Research reports. Four investment analysts have rated the stock with a ...
 Ticker Report2 weeks ago Zacks: Brokerages Set $19.25 Target Price for vTv Therapeutics Inc (NASDAQ:VTVT)  WKRB News1 month ago

Recent Research Analysts Ratings Changes for vTv Therapeutics (VTVT)

A number of research firms have changed their ratings and price targets for vTv Therapeutics (NASDAQ: VTVT): 7/6/2016 vTv Therapeutics was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to ...
 SleekMoney3 weeks ago

Investment Analysts Downgrades for July, 6th (VGZ, VIVO, VNDA, VR, VRNS, VSH, VTVT, WBMD, WEYS, WK)

Investment Analysts downgrades for Wednesday, July 6th: Vista Gold Corp. (NYSEMKT:VGZ) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, Vista Gold Corp. is a mining company which ...
 SleekMoney3 weeks ago

Stock Analysts Downgrades for June, 30th (CAT, GS, ON, VIVO, VNTV, VRTS, VTVT, WEICY, WEX, WNC)

Stock Analysts downgrades for Thursday, June 30th: Caterpillar (NYSE:CAT) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, The Brexit has dealt a blow to Caterpillar given its sizeable ...
 SleekMoney4 weeks ago

Equities Research Analysts Downgrades for May, 18th (DPM, NRZ, OKE, OKS, PKG, SAAS, VSLR, VSTO, VTVT, WGL)

Equities Research Analysts downgrades for Wednesday, May 18th: DCP Midstream Partners, (NYSE:DPM) was downgraded by analysts at US Capital Advisors from an overweight rating to a hold rating. New Residential Investment Corp (NYSE:NRZ) was downgraded ...
 SleekMoney2 months ago Equities Research Analysts Upgrades for June, 24th (BWLD, EMES, INTU, LZB, MEI, MFG, MNGPY, MXCHY, NK, NPSNY)  American Banking News - Forex1 month ago

Hyundai India Is All Set To Hike Pricing Of Creta Compact SUV

Hyundai Motors India regularly updates the pricing of its popular vehicles. Now, by September 2016, several of its products could witness a considerable price hike. The Hyundai Creta is most likely to receive a price hike according to several ...
 DriveSpark.com1 hour ago Hyundai i20 sales cross 10 lakh in India  Rush Lane1 week ago Hyundai Creta SUV sales to cross 1 lakh soon  International Business Times India1 week ago Top 4 new upcoming compact SUV/crossovers in India in 2016  Burn Your Fuel1 week ago

Hyundai Creta S+ diesel & SX+ Petrol automatic launched in Goa

Hyundai Creta now available in 3 automatic variants. Hyundai has launched automatic versions of the Creta both in petrol and diesel engine options. Automatic transmission on the petrol is offered on the top variant 1.6 SX+ only and is priced at ...
 Goa On Wheels11 hours ago Hyundai Elite i20 Automatic to be launched soon  Motoroids.com4 days ago Hyundai Creta S+ diesel automatic launched at Rs. 13.56 lakh; bookings, availability and everything you need to know  International Business Times India6 days ago Hyundai Creta S Diesel Automatic launched, Price INR 13.56 lakh  Bombay News.Net6 days ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less